Skip to main content

Lynx1 Capital Management LP

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1910456 DORADO, PR

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$163,225,335
+$35,854,000 QoQ
Shares Held
8,963,500
0.0% QoQ
Ownership
13.9%
of shares outstanding
% of Portfolio
18.86%
of 13F equity value
Holder Rank
#2
of 182 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lynx1 Capital Management LP holds $865,408,538 across 26 Biotechnology names. CGEM ranks #2 (18.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 CGEM
Cullinan Therapeutics, Inc.
This page
8,963,500 $163,225,335

All Filings in CGEM

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $163,225,335 8,963,500
2026-03-31 $127,371,335 8,963,500
2025-12-31 $92,772,225 8,963,500
2025-10-08 $55,141,591 8,549,084
2025-09-30 $34,192,913 5,766,090
2025-06-30 $33,138,340 4,400,842
2025-03-31 $24,343,015 3,215,722
2024-12-31 $15,319,943 1,257,795
2024-09-30 $6,877,294 410,830
2024-06-30 $6,580,513 377,323
2023-06-30 $1,238,077 115,063